
iShares MSCI USA ESG Screened UCITS ETF USD (Acc) USD
ETF · USD
Price
$14.78
Cap
$16.5B
Earnings
—
30d Trend
+2%
Near 52-week highs — limited upside before resistance
Key macro factors
**US Inflation and Interest Rate Expectations:** The elevated US March CPI of 3.3% and a bleaker April outlook could lead the Federal Reserve to maintain or adopt a more hawkish stance on interest rates. This typically impacts the valuation of growth stocks, which are a significant component of the MSCI USA Screened Index tracked by this ETF, by increasing the discount rate for future earnings.
**Geopolitical Stability and Oil Prices:** While Trump's extension of the US-Iran ceasefire has calmed oil markets, the underlying tensions and previous escalations (Iran War Escalation, Hormuz Blockade Drive Oil Volatility) highlight ongoing geopolitical risks. Such instability can cause broad market volatility and dampen investor sentiment towards equities, including those held by SASU, if it signals broader economic disruptions or higher energy costs.
**ESG Investing Trends:** As an 'ESG Screened' ETF, SASU's performance and asset flows are inherently linked to the prevailing trends and investor demand for Environmental, Social, and Governance compliant investments. Continued global emphasis on sustainable investing will likely provide support for this ETF, while any shift away from ESG mandates could pose a headwind.
The iShares MSCI USA Screened UCITS ETF USD (Acc) is an accumulating, passively managed exchange-traded fund, domiciled in Ireland and listed on the London Stock Exchange and SIX Swiss Exchange. It aims to replicate the performance of the MSCI USA ESG Screened Index by providing broad exposure to large- and mid-cap U.S. equities, while excluding companies that do not meet defined ESG criteria.
QUANT SCORE
Want full analysis on every stock?
Brain47 provides AI-powered research across 72,000+ instruments. Stocks, ETFs, REITs and more.
Join Brain47 — FreeGenerated by Brain47 AI. Educational research only. Not financial advice. Brain47 is not authorised by the FCA to provide investment advice.
